跳至主要内容
临床试验/IRCT20190829044642N1
IRCT20190829044642N1已完成3 期

The study of the effects of amlodipine addition to combination therapy of Deferiprone and Deferoxamine to reduce cardiac iron overload measurable with T2*MRI in thalassemic patients

Arak University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
5 years 至 no limit(—)
性别
All

入选标准

  • 1. All patients had informed consent to participate in the study.
  • 2- All thalassemia major patients referring to Amir Kabir Hospital, Arak, over 5 years old.
  • .3. All healthy children without any underlying hematologic or hereditary diseases except major thalassemia

排除标准

  • All patients who did not have informed consent to participate and continue to participate in the study.
  • All patients who will undergo a chelation therapy strategy during the 12 months of study due to changes.
  • All patients with advanced heart failure or Ef less than 30% or AV block
  • All patients with MRI contraindication
  • All patients with liver disorders, hepatitis B and C, HIV, any inflammation and renal failure
  • All patients who have complications with amlodipine include edema, hypotension, palpitations, etc

研究者

相似试验